Chilosi, Marco

Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis

Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedical Imaging and Pathology Studies

Cited by 708

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

Bonadonna, P., Perbellini, O., Passalacqua, G., Caruso, B., Colarossi, S., Dal Fior, D., Castellani, L., Bonetto, C., Frattini, F., Dama, A., et al. (2009) · Journal of Allergy and Clinical Immunology

Mast cells and histamineFood Allergy and Anaphylaxis Research

Cited by 392

Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis

Zanotti, R., Bonadonna, P., Bonifacio, M., Artuso, A., Schena, D., Rossini, M., Perbellini, O., Colarossi, S., Chilosi, M., & Pizzolo, G. (2011) · Haematologica

Mast cells and histaminePlatelet Disorders and Treatments

Cited by 61

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab

Bonanno, L., De Paoli, A., Zulato, E., Esposito, G., Calabrese, F., Favaretto, A., Santo, A., Conte, A. D., Chilosi, M., Oniga, F., et al. (2017) · Clinical Cancer Research

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 53